Cassava Sciences | PTIE - Equity Capital And Reserves


Cassava Sciences reported $81.57M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 50.83B 0 Sep/2025
Amgen USD 9.62B 2.19B Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Cassava Sciences USD 81.57M 6.4M Sep/2025
Eisai JPY 854.43B 25.92B Sep/2025
Eli Lilly USD 23.79B 5.52B Sep/2025
Geron USD 248.71M 10.82M Sep/2025
J&J USD 78.47B 0 Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025